{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:21:31Z","timestamp":1792794091694,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000},"content-version":"vor","delay-in-days":1651,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Paul Calabresi Career Development Award for Clinical Oncology","award":["UO1CA232947"],"award-info":[{"award-number":["UO1CA232947"]}],"id":[{"id":"https:\/\/ror.org\/02xjhr934","id-type":"ROR","asserted-by":"crossref"}]},{"name":"ASCO Cancer Foundation 2010 Young Investigator Award","award":["K12CA132783-03"],"award-info":[{"award-number":["K12CA132783-03"]}],"id":[{"id":"https:\/\/ror.org\/009yhf078","id-type":"ROR","asserted-by":"crossref"}]},{"name":"RTICC, Instituto de Salud Carlos III","award":["RD12\/0036\/0029"],"award-info":[{"award-number":["RD12\/0036\/0029"]}],"id":[{"id":"https:\/\/ror.org\/00ca2c886","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"crossref","award":["UL1 RR025750 and KL2 RR025749"],"award-info":[{"award-number":["UL1 RR025750 and KL2 RR025749"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1093\/annonc\/mdv036","type":"journal-article","created":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T00:39:10Z","timestamp":1422491950000},"page":"958-966","source":"Crossref","is-referenced-by-count":93,"title":["Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma"],"prefix":"10.1016","volume":"26","author":[{"given":"S.K.","family":"Barta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mounier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Tirelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Galicier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Boue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.F.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Dunleavy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Wyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Remick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.D.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Noy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Sparano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdv036_bb0010","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.cco.0000239883.23839.ac","article-title":"Update in HIV lymphoma","volume":"18","author":"Noy","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.1093\/annonc\/mdv036_bb0015","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/CCO.0b013e3282c8c835","article-title":"HIV-associated lymphoma: the evidence for treating aggressively but with caution","volume":"19","author":"Sparano","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"10.1093\/annonc\/mdv036_bb0020","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/blood-2010-01-262717","article-title":"HIV-associated lymphoma","volume":"115","author":"Levine","year":"2010","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv036_bb0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/CCO.0b013e3283094ec7","article-title":"Management of AIDS-related lymphoma","volume":"20","author":"Levine","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"10.1093\/annonc\/mdv036_bb0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.2012.7961","article-title":"Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel","volume":"308","author":"Thompson","year":"2012","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdv036_bb0035","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"Deeks","year":"2013","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdv036_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.beha.2012.01.001","article-title":"HIV-associated lymphoma","volume":"25","author":"Kaplan","year":"2012","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1093\/annonc\/mdv036_bb0045","first-page":"445","article-title":"Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3\/97 study","volume":"88","author":"Oriol","year":"2003","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdv036_bb0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/cncr.23522","article-title":"High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients","volume":"113","author":"Oriol","year":"2008","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdv036_bb0055","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bjh.12020","article-title":"Safety and activity of a new intensive short-term chemoimmunotherapy in HIV-positive patients with Burkitt lymphoma","volume":"159","author":"Ferreri","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdv036_bb0060","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/QAD.0b013e3283301578","article-title":"Excellent immunological recovery following CODOX-M\/IVAC, an effective intensive chemotherapy for HIV-associated Burkitt's lymphoma","volume":"24","author":"Montoto","year":"2010","journal-title":"AIDS"},{"key":"10.1093\/annonc\/mdv036_bb0065","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/QAD.0000000000000133","article-title":"HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era","volume":"28","author":"Coutinho","year":"2014","journal-title":"AIDS"},{"key":"10.1093\/annonc\/mdv036_bb0070","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/QAD.0000000000000071","article-title":"Malignancies in HIV\/AIDS: from epidemiology to therapeutic challenges","volume":"28","author":"Rubinstein","year":"2014","journal-title":"AIDS"},{"key":"10.1093\/annonc\/mdv036_bb0075","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1200\/JCO.2005.02.9355","article-title":"Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy","volume":"23","author":"Lim","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv036_bb0080","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.1998.16.11.3601","volume":"16","author":"Straus","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv036_bb0085","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1200\/JCO.2005.11.973","article-title":"AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy","volume":"23","author":"Lim","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv036_bb0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/QAI.0b013e31802bb5d0","article-title":"Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors","volume":"44","author":"Miralles","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1093\/annonc\/mdv036_bb0095","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1182\/blood-2013-04-498964","article-title":"Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients","volume":"122","author":"Barta","year":"2013","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv036_bb0100","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jnci\/djt158","article-title":"Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era","volume":"105","author":"Gopal","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdv036_bb0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/1055-9965.EPI-13-0040","article-title":"The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992\u20132009","volume":"22","author":"Shiels","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdv036_bb0110","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1200\/JCO.2005.02.9561","article-title":"Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era","volume":"23","author":"Spina","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdv036_bb0115","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2011-08-373738","article-title":"How I treat HIV-associated lymphoma","volume":"119","author":"Dunleavy","year":"2012","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv036_bb0120","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood.V122.21.639.639","article-title":"A modified dose intensive R- CODOX-M\/IVAC for HIV-associated Burkitt and Atypical Burkitt Lymphoma (BL) demonstrates high cure rates and low toxicity: prospective multicenter phase II trial of the AIDS Malignancy Consortium (AMC 048)","volume":"122","author":"Noy","year":"2013","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv036_bb0125","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa1308392","article-title":"Low-intensity therapy in adults with Burkitt's lymphoma","volume":"369","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdv036_bb0130","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/jnci\/djt192","article-title":"Implications of the shifting pathobiology of AIDS-related lymphoma","volume":"105","author":"Dunleavy","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdv036_bb0135","first-page":"508","article-title":"International prognostic index is the best prognostic factor for survival in patients with AIDS-related non-Hodgkin's lymphoma treated with CHOP. A multivariate study of 46 patients","volume":"83","author":"Navarro","year":"1998","journal-title":"Haematologica"},{"key":"10.1093\/annonc\/mdv036_bb0140","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood-2005-09-3600","article-title":"AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy [see comment]","volume":"107","author":"Mounier","year":"2006","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdv036_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-143-4-200508160-00007","article-title":"A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy","volume":"143","author":"Bower","year":"2005","journal-title":"Ann Intern Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419314991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419314991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/26\/5\/958\/17460458\/mdv036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T03:48:18Z","timestamp":1624506498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419314991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0923753419314991"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdv036","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}